Related Experiment Videos
Restorative proctocolectomy for ulcerative colitis complicated by colorectal cancer
Stephen R Gorfine1, Michael T Harris, David S Bub
1The Mount Sinai School of Medicine, Department of Surgery, New York, New York, USA. srgny@nyc.rr.com
Diseases of the Colon and Rectum
|October 16, 2004
Summary
Restorative proctocolectomy is a viable option for ulcerative colitis patients with colorectal cancer, with outcomes tied to cancer stage. Functional results are comparable to patients without cancer.
Area of Science:
- Gastroenterology
- Surgical Oncology
- Colorectal Surgery
Background:
- Restorative proctocolectomy (RPC) with ileal pouch-anal anastomosis is standard for chronic ulcerative colitis (UC).
- The efficacy of RPC in UC patients with coexisting colorectal carcinoma (CRC) remains unclear.
Purpose of the Study:
- To evaluate clinical outcomes of UC patients with CRC undergoing RPC.
- To assess oncologic and functional results after RPC in this patient cohort.
Main Methods:
- Prospective follow-up of 756 UC patients post-RPC.
- Analysis of 45 patients (5.9%) diagnosed with invasive CRC (31 colon, 14 rectum).
- Detailed tracking of cancer stage, adjuvant therapy, oncologic outcomes, and functional results.
Main Results:
- 21 patients underwent staged surgery; 27 received adjuvant chemotherapy.
- Chemotherapy was safely administered to nondiverted patients.
- Survival was linked to cancer stage, with Stage III having poorer outcomes.
- Long-term functional results (bowel frequency, continence) were similar to UC patients without CRC.
Conclusions:
- RPC, as a single or staged procedure, is a viable option for selected UC patients with CRC.
- Cancer stage is a key prognostic factor.
- Adjuvant chemotherapy is safe in nondiverted patients; radiotherapy protocols require further study.